ENOB
Price:
$0.7125
Market Cap:
$32.92M
Enochian Biosciences, Inc. is a pre-clinical biotechnology firm dedicated to the research and advancement of novel pharmaceutical and biological agents. Its primary focus lies in developing treatments for a range of human diseases, including human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza, coronavirus infections, and various cancers. The company's leading investigational products encompass ENOB-HV-01, an autologous therapy aimed at achieving an HIV cure; ENOB-HV-11, a preventative HIV vaccine candidate; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, which targets the HBV polymerase. Beyond these primary programs, Enochian Biosciences' developmental pipeline als...[Read more]
Industry
Biotechnology
IPO Date
2018-02-07
Stock Exchange
NASDAQ
Ticker
ENOB
According to Enochian Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.19. This represents a change of 161.79% compared to the average of 0.07 of the last 4 quarters.
The mean historical Current Ratio of Enochian Biosciences, Inc. over the last ten years is 5.08. The current 0.19 Current Ratio has changed 281.20% with respect to the historical average. Over the past ten years (40 quarters), ENOB's Current Ratio was at its highest in in the March 2018 quarter at 18.83. The Current Ratio was at its lowest in in the December 2025 quarter at 0.03.
Average
5.08
Median
1.44
Minimum
0.04
Maximum
18.04
Discovering the peaks and valleys of Enochian Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.18%
Maximum Annual Current Ratio = 18.04
Minimum Annual Increase = -86.62%
Minimum Annual Current Ratio = 0.04
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.04 | -45.53% |
| 2024 | 0.07 | -71.68% |
| 2023 | 0.23 | -84.30% |
| 2022 | 1.48 | -86.62% |
| 2021 | 11.08 | 65.44% |
| 2020 | 6.70 | -40.47% |
| 2019 | 11.25 | -37.62% |
| 2018 | 18.04 | 1.18% |
| 2017 | 1.40 | 189.21% |
| 2016 | 0.49 | -83.08% |
The current Current Ratio of Enochian Biosciences, Inc. (ENOB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.11
5-year avg
2.58
10-year avg
5.08
Enochian Biosciences, Inc.’s Current Ratio is less than GreenLight Biosciences Holdings (2.01), less than Rein Therapeutics Inc. (0.40), less than bluebird bio, Inc. (0.55), less than Spyre Therapeutics, Inc. (8.97), less than Magenta Therapeutics, Inc. (29.25), less than AlloVir, Inc. (12.14), less than Pluristem Therapeutics Inc. (0.33), less than Eyenovia, Inc. (1.97), less than ERYTECH Pharma S.A. (1.06), less than LianBio (1.47K),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.01 | $45.43M | |
| 0.40 | $26.42M | |
| 0.55 | $48.67M | |
| 8.97 | $5.04B | |
| 29.25 | $42.44M | |
| 12.14 | $49.48M | |
| 0.33 | $40.85M | |
| 1.97 | $38.59M | |
| 1.06 | $47.38M | |
| 1.47K | $12.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enochian Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enochian Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Enochian Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Enochian Biosciences, Inc. (ENOB)?
What is the highest Current Ratio for Enochian Biosciences, Inc. (ENOB)?
What is the 3-year average Current Ratio for Enochian Biosciences, Inc. (ENOB)?
What is the 5-year average Current Ratio for Enochian Biosciences, Inc. (ENOB)?
How does the current Current Ratio for Enochian Biosciences, Inc. (ENOB) compare to its historical average?